Retrospective and Prospective, Multicenter Study on T.E.S.S.® V3 (Implants and Instrumentation)
This is a multicenter, retrospective and prospective, non-controlled post market surveillance study. The objectives of this study are to confirm safety, performance and clinical benefits of the T.E.S.S.® Version 3 Anatomic and Reverse Modular Total shoulder prosthesis and its instrumentation.
• Patient is 18 years or older and skeletally mature
• Patient is capable of understanding the surgeon's explanations and following his instructions, able and willing to participate in the follow-up program
• Patient gave consent to take part in the study by signing the Informed Consent Form
• Patient operated from January 2013 and received the Anatomic or Reverse T.E.S.S.® V3 Modular Total Shoulder System to relieve pain and restore the joint function
• Patient has adequate quality and quantity of bone stock to support the prosthesis
• Patient meets at least one of the following indications:
⁃ For anatomic type:
• Centered osteoarthritis of the shoulder
• Humeral head fractures
• Rheumatoid arthritis (with intact rotator cuff)
• Avascular necrosis of the humeral head
• Revision of a hemi-arthroplasty with a total arthroplasty
• Revision of a reverse prosthesis with an anatomic prosthesis
• Revision to increase the size of the stem (length and/or diameter)
• Revision of a glenoid prosthesis, a glenoid insert or a competitor's prosthesis
⁃ For reverse type:
• Offset osteoarthritis of the shoulder
• Massive and non-repairable rotator cuff tears
• Rheumatoid arthritis (with degenerative rotator cuff)
• Revision of an anatomic prosthesis with a reverse prosthesis
• Revision to increase the size of the stem (length and/or diameter)
• Revision of a glenoid prosthesis, a glenoid insert or a competitor's prosthesis